Artículo:

PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D

Autor:

ENEDA TOSKA

HATICE U. OSMANBEYOGLU

PAU CASTEL

Resumen:

Tumor cells develop resistance to a drug used to treat breast cancer through a chromatin remodeling mechanism.

Página:

1324

Publicación:

Science

Volúmen:

355

Número:

6331

Periodo:

24 marzo 2017

ISSN:

00368075

SrcID:

00368075-2017-03-24.txt